Biogenics Research Chamber, LLC   Report issue

For profit Phase 4
Founded: San Antonio TX United States (2007)

Organization Overview

First Clinical Trial
2015
NCT02543346
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

cetirizine (zyrtec) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Rhinitis (Phase 4)

Rhinitis, Allergic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1